loading

Astria Therapeutics Inc Azioni (ATXS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
3.18%
35.82
36.99 29.59 29.01 28.80
Operating Income/Loss
3.18%
-35.82
-36.99 -29.59 -29.01 -28.80
Nonoperating Income/Loss
15.76%
2.768
3.286 3.965 4.48 4.631
Income/Loss From Continuing Operations Before Tax
1.95%
-33.05
-33.71 -25.63 -24.53 -24.17
Income/Loss From Continuing Operations After Tax
1.95%
-33.05
-33.71 -25.63 -24.53 -24.17
Net Income/Loss
1.95%
-33.05
-33.71 -25.63 -24.53 -24.17
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
58.01
58.01 0.6192 57.82 56.49
Diluted Average Shares
0.00%
58.01
58.01 0.6192 57.82 56.49
Basic Earnings Per Share
1.72%
-0.57
-0.58 -0.44 -0.42 -0.43
Diluted Earnings Per Share
1.72%
-0.57
-0.58 -0.44 -0.42 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.36
price down icon 0.93%
$83.10
price down icon 3.56%
$27.82
price down icon 2.76%
$96.74
price down icon 7.26%
$145.93
price up icon 0.10%
biotechnology ONC
$324.34
price down icon 3.38%
Capitalizzazione:     |  Volume (24 ore):